https://blueridgecancercare.com/genetic-testinghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-06-22https://blueridgecancercare.com/locationshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/locations/Pulaski.jpgPulaskiPulaskihttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/locations/Rke_1.jpgRke_1Rke_1https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/locations/Wytheville.jpgWythevilleWythevillehttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/locations/Lexington.jpgLexingtonLexingtonhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/locations/Bedford.jpgBedfordBedfordhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/locations/Blacksburg.jpgBlacksburgBlacksburghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/locations/Vance_-_Princeton_wall_Day.jpgVance_-_Princeton_wall_DayVance_-_Princeton_wall_Dayhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/locations/Salem.jpgSalemSalemhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/locations/Fairlea_.jpgFairlea_Fairlea_https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/locations/Franklin.jpgFranklinFranklinhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/locations/Emmett.jpgEmmettEmmetthttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-22https://blueridgecancercare.com/non-small-cell-lung-cancer/biomarker-testinghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Non-Small-Cell-Lung-01.jpgBRCC-Cancer-Sub-Banner-Non-Small-Cell-Lung-01BRCC-Cancer-Sub-Banner-Non-Small-Cell-Lung-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/brcc-support-grouphttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/endometrial-cancer/treatment-optionshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Endometrial-01.jpgBRCC-Cancer-Sub-Banner-Endometrial-01BRCC-Cancer-Sub-Banner-Endometrial-012026-04-30https://blueridgecancercare.com/cervical-cancer/treatment-optionshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Cervical-01.jpgBRCC-Cancer-Sub-Banner-Cervical-01BRCC-Cancer-Sub-Banner-Cervical-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/pancreatic-cancerhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Pancreas-01.jpgBRCC-Cancer-Sub-Banner-Pancreas-01BRCC-Cancer-Sub-Banner-Pancreas-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/physicians/jeffrey-lantz-do2026-07-13https://blueridgecancercare.com/cervical-cancer/diagnosishttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Cervical-01.jpgBRCC-Cancer-Sub-Banner-Cervical-01BRCC-Cancer-Sub-Banner-Cervical-012026-04-30https://blueridgecancercare.com/prostate-cancer/screening-diagnosishttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Prostate-01.jpgBRCC-Cancer-Sub-Banner-Prostate-01BRCC-Cancer-Sub-Banner-Prostate-012026-04-30https://blueridgecancercare.com/physicians/daniel-s-temeles-md2026-07-13https://blueridgecancercare.com/research-institute/available-trials/breast-cancer-minimalmolecular-residual-disease-detection-and-therapy-monitoring-in-patients-with-early-stage-tnbc-phase-i2026-07-02https://blueridgecancercare.com/pancreatic-cancer/treatment-optionshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Pancreas-01.jpgBRCC-Cancer-Sub-Banner-Pancreas-01BRCC-Cancer-Sub-Banner-Pancreas-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/research-institute/available-trials/pf-08046054sgn-pdl1v-vs-docetaxel-in-patients-with-pd-l1-nsclc2026-07-02https://blueridgecancercare.com/support-serviceshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/sarcoma/staginghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Sarcoma-01.jpgBRCC-Cancer-Sub-Banner-Sarcoma-01BRCC-Cancer-Sub-Banner-Sarcoma-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/locations/alleghany2026-06-02https://blueridgecancercare.com/sarcomahttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Sarcoma-01.jpgBRCC-Cancer-Sub-Banner-Sarcoma-01BRCC-Cancer-Sub-Banner-Sarcoma-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/multiple-myelomahttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Multiple-Myeloma-01.jpgBRCC-Cancer-Sub-Banner-Multiple-Myeloma-01BRCC-Cancer-Sub-Banner-Multiple-Myeloma-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/research-institute/available-trials/mk-5684-vs.-abiraterone-or-enzalutamide-in-prostate-cancer-patients2026-07-02https://blueridgecancercare.com/cervical-cancer/staginghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Cervical-01.jpgBRCC-Cancer-Sub-Banner-Cervical-01BRCC-Cancer-Sub-Banner-Cervical-012026-04-30https://blueridgecancercare.com/physicians/joanna-young-do2026-07-13https://blueridgecancercare.com/leukemia/diagnosishttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Leukemia-01.jpgBRCC-Cancer-Sub-Banner-Leukemia-01BRCC-Cancer-Sub-Banner-Leukemia-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/research-institute/available-trials/pf-08634404-vs.-pf-08634404-other-treatments-in-untreated-metastatic-renal-cell-carcinoma2026-07-02https://blueridgecancercare.com/physicians/vincent-cassidy-md-mba2026-07-13https://blueridgecancercare.com/colon-rectal-cancer/staginghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Colon-01.jpgBRCC-Cancer-Sub-Banner-Colon-01BRCC-Cancer-Sub-Banner-Colon-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/research-institute/available-trials/nx-5948-in-patients-wrelapsedrefractory-cll-or-sll-previously-treated-wa-btki-and-a-bcl-2i2026-07-02https://blueridgecancercare.com/mesothelioma/staginghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Mesothelioma-01.jpgBRCC-Cancer-Sub-Banner-Mesothelioma-01BRCC-Cancer-Sub-Banner-Mesothelioma-012026-04-30https://blueridgecancercare.com/nonmelanoma-skin-cancer/staginghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Non-Melanoma-Skin-01.jpgBRCC-Cancer-Sub-Banner-Non-Melanoma-Skin-01BRCC-Cancer-Sub-Banner-Non-Melanoma-Skin-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/physicians/robert-c-heath-md2026-07-13https://blueridgecancercare.com/physicians/david-asher-md2026-07-13https://blueridgecancercare.com/advanced-practice-providers/charlene-m-jordan-msn-fnp-bc2026-04-29https://blueridgecancercare.com/hodgkin-lymphoma/staginghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Hodgkin-Lymphoma-01.jpgBRCC-Cancer-Sub-Banner-Hodgkin-Lymphoma-01BRCC-Cancer-Sub-Banner-Hodgkin-Lymphoma-012026-04-30https://blueridgecancercare.com/ovarian-cancer/treatment-optionshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Ovarian-01.jpgBRCC-Cancer-Sub-Banner-Ovarian-01BRCC-Cancer-Sub-Banner-Ovarian-012026-04-30https://blueridgecancercare.com/nonmelanoma-skin-cancerhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Non-Melanoma-Skin-01.jpgBRCC-Cancer-Sub-Banner-Non-Melanoma-Skin-01BRCC-Cancer-Sub-Banner-Non-Melanoma-Skin-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/research-institute/available-trials/elacestrant-vs-soc-in-patients-with-erher-early-breast-cancer2026-07-02https://blueridgecancercare.com/advanced-practice-providers/kristen-auckland-msn-fnp-c2026-04-29https://blueridgecancercare.com/physicianshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/BRCC_2-20-207365.jpgBRCC_2-20-207365BRCC_2-20-207365https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/Buck.jpgBuckBuckhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/Daniel_Temeles_2.jpgDaniel_Temeles_2Daniel_Temeles_2https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/Heath_2.jpgHeath_2Heath_2https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/Sheela_web.jpgSheela_webSheela_webhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/Andrew_Fintel-r.jpgAndrew_Fintel-rAndrew_Fintel-rhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/Joey_Mock_web.jpgJoey_Mock_webJoey_Mock_webhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/Joshua_Morales-r.jpgJoshua_Morales-rJoshua_Morales-rhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/Ojomo_2.jpgOjomo_2Ojomo_2https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/Jeff_Lantz.jpgJeff_LantzJeff_Lantzhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/BRCC-Doctor-HallwayBG_4.jpgBRCC-Doctor-HallwayBG_4BRCC-Doctor-HallwayBG_4https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/BRCC_2-20-207306.jpgBRCC_2-20-207306BRCC_2-20-207306https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/BRCC_2-20-207360.jpgBRCC_2-20-207360BRCC_2-20-207360https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/David_Asher-206476.jpgDavid_Asher-206476David_Asher-206476https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/Jerome_Goldschmidt-r.jpgJerome_Goldschmidt-rJerome_Goldschmidt-rhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/Heather_Brooks-r.jpgHeather_Brooks-rHeather_Brooks-rhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/Kim_Aderhold_BRCC_Doctor-1.jpgKim_Aderhold_BRCC_Doctor-1Kim_Aderhold_BRCC_Doctor-1https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/Cassidy.jpgCassidyCassidyhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/Dr_Giovanni_Elia.jpgDr_Giovanni_EliaDr_Giovanni_Eliahttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/Skelton.jpgSkeltonSkeltonhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/BRCC_Dr_Headshot-206476.jpgBRCC_Dr_Headshot-206476BRCC_Dr_Headshot-206476https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/Adams.jpgAdamsAdamshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/John_Rogers-r.jpgJohn_Rogers-rJohn_Rogers-rhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/Young_1.jpgYoung_1Young_1https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/Amanda_Gillespie-Twardy-r-1.jpgAmanda_Gillespie-Twardy-r-1Amanda_Gillespie-Twardy-r-12026-07-13https://blueridgecancercare.com/bladder-cancer/staginghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Bladder-01.jpgBRCC-Cancer-Sub-Banner-Bladder-01BRCC-Cancer-Sub-Banner-Bladder-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/research-institute/available-trials/azd5305-in-patients-with-brcam-localized-high-risk-prostate-cancer2026-07-02https://blueridgecancercare.com/research-institute/available-trials/pumitamig-chemotherapy-vs.-bevacizumab-chemotherapy-in-patients-with-previously-untreated-metastatic-colon-cancer2026-07-02https://blueridgecancercare.com/pancreatic-cancer/staginghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Pancreas-01.jpgBRCC-Cancer-Sub-Banner-Pancreas-01BRCC-Cancer-Sub-Banner-Pancreas-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/small-cell-lung-cancerhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Small-Cell-01.jpgBRCC-Cancer-Sub-Banner-Small-Cell-01BRCC-Cancer-Sub-Banner-Small-Cell-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/advanced-practice-providers/jolee-preston-msn-np-c2026-04-29https://blueridgecancercare.com/pancreatic-cancer/diagnosishttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Pancreas-01.jpgBRCC-Cancer-Sub-Banner-Pancreas-01BRCC-Cancer-Sub-Banner-Pancreas-012026-04-30https://blueridgecancercare.com/research-institute/available-trials/pumitamig-vs.-durvalumab-wunresectable-stage-ii-nsclc-wo-progression-after-platinum-based-concurrent-chemoradiation2026-07-02https://blueridgecancercare.com/melanoma/diagnosishttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Melanoma-01.jpgBRCC-Cancer-Sub-Banner-Melanoma-01BRCC-Cancer-Sub-Banner-Melanoma-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/terms-of-usehttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-23https://blueridgecancercare.com/multiple-myeloma/treatment-optionshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Multiple-Myeloma-01.jpgBRCC-Cancer-Sub-Banner-Multiple-Myeloma-01BRCC-Cancer-Sub-Banner-Multiple-Myeloma-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/oral-cancerhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Oral-01.jpgBRCC-Cancer-Sub-Banner-Oral-01BRCC-Cancer-Sub-Banner-Oral-012026-04-30https://blueridgecancercare.com/medical-oncologyhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/physicians/joseph-mock-md2026-07-13https://blueridgecancercare.com/kidney-cancerhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Site-Sub-00-Kidney-Cancer.jpgBRCC-Site-Sub-00-Kidney-CancerBRCC-Site-Sub-00-Kidney-Cancerhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/research-institute/available-trials/a-phase-12-study-to-evaluate-the-safety-and-efficacy-of-patritumab-deruxtecan-in-gastrointestinal-cancers2026-07-02https://blueridgecancercare.com/research-institute/available-trials/a-study-of-disitamab-vedotin-in-adults-with-her2-expressing-advanced-breast-cancer2026-07-02https://blueridgecancercare.com/research-institute/available-trials/study-of-mk-2870-as-a-single-agent-and-pembrolizumab-vs-physicians-choice-in-patients-with-hrher-breast-cancer2026-07-02https://blueridgecancercare.com/survivorshiphttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/Screenshot_2026-06-01_150543.jpgScreenshot_2026-06-01_150543Screenshot_2026-06-01_150543https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-06-23https://blueridgecancercare.com/multiple-myeloma/staginghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Multiple-Myeloma-01.jpgBRCC-Cancer-Sub-Banner-Multiple-Myeloma-01BRCC-Cancer-Sub-Banner-Multiple-Myeloma-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/research-institute/available-trials/pumitamig-chemotherapy-vs.-nivolumab-chemotherapy-in-untreated-metastatic-gastric-gastroesophageal-or-gej2026-07-02https://blueridgecancercare.com/research-institute/available-trials/phase-2-study-of-brentuximab-vedotin-with-pembrolizumab-in-subjects-with-metastatic-solid-tumors2026-07-02https://blueridgecancercare.com/physicians/donald-c-vile-md2026-07-13https://blueridgecancercare.com/advanced-practice-providers/megen-mellom-msn-fnp-c2026-04-29https://blueridgecancercare.com/ovarian-cancerhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Ovarian-01.jpgBRCC-Cancer-Sub-Banner-Ovarian-01BRCC-Cancer-Sub-Banner-Ovarian-012026-04-30https://blueridgecancercare.com/kidney-cancer/diagnosishttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Site-Sub-00-Kidney-Cancer.jpgBRCC-Site-Sub-00-Kidney-CancerBRCC-Site-Sub-00-Kidney-Cancerhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/research-institute/patient-stories/https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC%20Research%20Institute%202026.pngBRCC Research Institute 2026BRCC Research Institute 2026https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/Donna_Salmons.jpgDonna_SalmonsDonna_Salmonshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/Debra%20Church.jpgDebra ChurchDebra Churchhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/Frank%20McClung.jpgFrank McClungFrank McClunghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/breast-cancer/reconstructionhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Breast-01.jpgBRCC-Cancer-Sub-Banner-Breast-01BRCC-Cancer-Sub-Banner-Breast-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/thyroid-cancer/diagnosishttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Thyroid-01.jpgBRCC-Cancer-Sub-Banner-Thyroid-01BRCC-Cancer-Sub-Banner-Thyroid-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/research-institute/available-trials/tucatinib-in-combination-wdoxil-for-her2-metastatic-breast-ca2026-07-02https://blueridgecancercare.com/sarcoma/treatment-optionshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Sarcoma-01.jpgBRCC-Cancer-Sub-Banner-Sarcoma-01BRCC-Cancer-Sub-Banner-Sarcoma-012026-04-30https://blueridgecancercare.com/prostate-cancerhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Prostate-01.jpgBRCC-Cancer-Sub-Banner-Prostate-01BRCC-Cancer-Sub-Banner-Prostate-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/research-institute/available-trials/rilvegostomig-bevacizumab-wor-wo-tremelimumab-as-first-line-treatment-in-advanced-hepatocellular-carcinoma2026-07-02https://blueridgecancercare.com/non-hodgkin-lymphoma/treatment-optionshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Non-Hodgkin-Lymphoma-01.jpgBRCC-Cancer-Sub-Banner-Non-Hodgkin-Lymphoma-01BRCC-Cancer-Sub-Banner-Non-Hodgkin-Lymphoma-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/hormone-therapyhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/research-institute/available-trials/gdc-6036-in-combination-wother-anti-cancer-therapies-in-untreated-metastatic-nsclc-wkras-g12c-mut2026-07-02https://blueridgecancercare.com/physicians/amanda-gillespie-twardy-md2026-07-29https://blueridgecancercare.com/physicians/sheenu-sheela-md-facp2026-07-13https://blueridgecancercare.com/research-institute/research-team/https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/Research%20Team/Dana_Selvia.jpgDana_SelviaDana_Selviahttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/Jerome_Goldschmidt-r.jpgJerome_Goldschmidt-rJerome_Goldschmidt-rhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/Research%20Team/Gayatri%20Chembula.jpgGayatri ChembulaGayatri Chembulahttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/Research%20Team/Tessa_Blair_2.jpgTessa_Blair_2Tessa_Blair_2https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/Research%20Team/Natasha%20Holt.jpgNatasha HoltNatasha Holthttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/Research%20Team/Katelyn%20Harris.jpgKatelyn HarrisKatelyn Harrishttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC%20Research%20Institute%202026.pngBRCC Research Institute 2026BRCC Research Institute 2026https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/Research%20Team/Kelly%20Johnson.jpgKelly JohnsonKelly Johnsonhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/Research%20Team/Andi%20Pollard.jpgAndi PollardAndi Pollardhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/Research%20Team/Monica%20Sarp.jpgMonica SarpMonica Sarphttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/BRCC_2-20-207360.jpgBRCC_2-20-207360BRCC_2-20-207360https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/Amanda_Gillespie-Twardy-r-1.jpgAmanda_Gillespie-Twardy-r-1Amanda_Gillespie-Twardy-r-1https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/Research%20Team/Holland_Ragland.jpgHolland_RaglandHolland_Raglandhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/BRCC_Dr_Headshot-206476.jpgBRCC_Dr_Headshot-206476BRCC_Dr_Headshot-206476https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/Research%20Team/Kelly%20Wade.jpgKelly WadeKelly Wadehttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/Research%20Team/Keisha_Smith.jpgKeisha_SmithKeisha_Smithhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/Research%20Team/Amber_Donovan_2.jpgAmber_Donovan_2Amber_Donovan_2https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/Research%20Team/Becky%20Schultz.jpgBecky SchultzBecky Schultzhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/Research%20Team/Taylor_Daly.jpgTaylor_DalyTaylor_Dalyhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/Buck.jpgBuckBuckhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/Research%20Team/Katie_Woods.jpgKatie_WoodsKatie_Woods2026-04-30https://blueridgecancercare.com/research-institute/available-trials/petosemtamab-investigators-choice-in-patients-wpreviously-treated-stage-iv-hnscc2026-07-02https://blueridgecancercare.com/nonmelanoma-skin-cancer/diagnosishttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Non-Melanoma-Skin-01.jpgBRCC-Cancer-Sub-Banner-Non-Melanoma-Skin-01BRCC-Cancer-Sub-Banner-Non-Melanoma-Skin-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/patient-advocacyhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/research-institute/available-trials/pasritamig-vs.-best-supportive-care-in-metastatic-castrate-resistant-prostate-cancer2026-07-02https://blueridgecancercare.com/melanoma/treatment-optionshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Melanoma-01.jpgBRCC-Cancer-Sub-Banner-Melanoma-01BRCC-Cancer-Sub-Banner-Melanoma-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/advanced-practice-providers/charlene-viers-fnp-c-gcra2026-04-29https://blueridgecancercare.com/physicians/mark-kochenderfer-md2026-07-13https://blueridgecancercare.com/non-small-cell-lung-cancerhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Non-Small-Cell-Lung-01.jpgBRCC-Cancer-Sub-Banner-Non-Small-Cell-Lung-01BRCC-Cancer-Sub-Banner-Non-Small-Cell-Lung-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/mesothelioma/treatment-optionshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Mesothelioma-01.jpgBRCC-Cancer-Sub-Banner-Mesothelioma-01BRCC-Cancer-Sub-Banner-Mesothelioma-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.comhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Site-Home-05-Cancer-Trials.jpgBRCC-Site-Home-05-Cancer-TrialsBRCC-Site-Home-05-Cancer-Trialshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/ASCO-Certified-Emblem-RGB-TM%5B84%5D%20(1).pngASCO-Certified-Emblem-RGB-TM[84] (1)ASCO-Certified-Emblem-RGB-TM[84] (1)https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/icons/Icon-First-Visit.svgIcon-First-VisitIcon-First-Visithttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Site-Home-03-Quality-Programs.jpgBRCC-Site-Home-03-Quality-ProgramsBRCC-Site-Home-03-Quality-Programshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Site-Home-00-Banner-01.jpgBRCC-Site-Home-00-Banner-01BRCC-Site-Home-00-Banner-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/icons/Icon-Our-Locations.svgIcon-Our-LocationsIcon-Our-Locationshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Site-Home-04-50-Years-01.jpgBRCC-Site-Home-04-50-Years-01BRCC-Site-Home-04-50-Years-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/Mallidi%20pic.jpgMallidi picMallidi pichttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Locations-Map.svgBRCC-Locations-MapBRCC-Locations-Maphttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/icons/Icon-Pay-My-Bill.svgIcon-Pay-My-BillIcon-Pay-My-Billhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Site-Home-00-Banner-02.jpgBRCC-Site-Home-00-Banner-02BRCC-Site-Home-00-Banner-02https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Site-Home-00-Banner-04.jpgBRCC-Site-Home-00-Banner-04BRCC-Site-Home-00-Banner-04https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/icons/Icon-Clinical-Trials.svgIcon-Clinical-TrialsIcon-Clinical-Trialshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Site-Home-01-Retail-Pharmacy.jpgBRCC-Site-Home-01-Retail-PharmacyBRCC-Site-Home-01-Retail-Pharmacyhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Site-Home-02-Genetic-Program.jpgBRCC-Site-Home-02-Genetic-ProgramBRCC-Site-Home-02-Genetic-Programhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Site-Home-00-Banner-03.jpgBRCC-Site-Home-00-Banner-03BRCC-Site-Home-00-Banner-032026-07-01https://blueridgecancercare.com/research-institute/available-trials/mk-1084-sq-pembrolizumab-mk-3475a-vs.-mk3475a-chemo-in-1st-line-kras-g12c-mutant-ncslc2026-07-02https://blueridgecancercare.com/targeted-therapyhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/prostate-cancer/gleason-scorehttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Prostate-01.jpgBRCC-Cancer-Sub-Banner-Prostate-01BRCC-Cancer-Sub-Banner-Prostate-012026-04-30https://blueridgecancercare.com/patient-formshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-07-15https://blueridgecancercare.com/research-institute/available-trials/petosemtamab-docetaxel-as-2nd-line-treatment-with-metastatic-nsclc2026-07-02https://blueridgecancercare.com/advanced-practice-providers/elizabeth-christman-pa-c2026-04-29https://blueridgecancercare.com/research/clinical-trial-phaseshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC%20Research%20Institute%202026.pngBRCC Research Institute 2026BRCC Research Institute 2026https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/colon-rectal-cancerhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Colon-01.jpgBRCC-Cancer-Sub-Banner-Colon-01BRCC-Cancer-Sub-Banner-Colon-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/locations/salem2026-06-02https://blueridgecancercare.com/advanced-practice-providers/kaitlin-hilliard-pa-c2026-04-29https://blueridgecancercare.com/oral-cancer/treatment-optionshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Oral-01.jpgBRCC-Cancer-Sub-Banner-Oral-01BRCC-Cancer-Sub-Banner-Oral-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/locations/pulaski2026-06-02https://blueridgecancercare.com/research/clinical-trial-faqshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC%20Research%20Institute%202026.pngBRCC Research Institute 2026BRCC Research Institute 20262026-04-30https://blueridgecancercare.com/research-institute/available-trials/a-phase-2-study-of-alisertib-in-patients-with-extensive-small-cell-lung-cancer2026-07-02https://blueridgecancercare.com/second-opinions-referralshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-29https://blueridgecancercare.com/hodgkin-lymphoma/diagnosishttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Hodgkin-Lymphoma-01.jpgBRCC-Cancer-Sub-Banner-Hodgkin-Lymphoma-01BRCC-Cancer-Sub-Banner-Hodgkin-Lymphoma-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/non-small-cell-lung-cancer/diagnosishttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Non-Small-Cell-Lung-01.jpgBRCC-Cancer-Sub-Banner-Non-Small-Cell-Lung-01BRCC-Cancer-Sub-Banner-Non-Small-Cell-Lung-012026-04-30https://blueridgecancercare.com/physicians/matthew-skelton-md2026-07-13https://blueridgecancercare.com/careershttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC%20About%20Us.jpgBRCC About UsBRCC About Us2026-04-30https://blueridgecancercare.com/symptom-management-serviceshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/physicians/Dr_Giovanni_Elia.jpgDr_Giovanni_EliaDr_Giovanni_Eliahttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-06-23https://blueridgecancercare.com/advanced-practice-providers/amy-butler-fnp2026-04-29https://blueridgecancercare.com/chemotherapyhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/ovarian-cancer/staginghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Ovarian-01.jpgBRCC-Cancer-Sub-Banner-Ovarian-01BRCC-Cancer-Sub-Banner-Ovarian-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/mesotheliomahttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Mesothelioma-01.jpgBRCC-Cancer-Sub-Banner-Mesothelioma-01BRCC-Cancer-Sub-Banner-Mesothelioma-012026-04-30https://blueridgecancercare.com/cancer-treatment-side-effects/https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/breast-cancer/treament-optionshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Breast-01.jpgBRCC-Cancer-Sub-Banner-Breast-01BRCC-Cancer-Sub-Banner-Breast-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-06-11https://blueridgecancercare.com/research-institute/available-trials/study-of-ivonescimab-vs.-pembrolizumab-for-first-line-treatment-of-nsclc2026-07-02https://blueridgecancercare.com/locations/lexington2026-06-08https://blueridgecancercare.com/liver-cancerhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Liver-01.jpgBRCC-Cancer-Sub-Banner-Liver-01BRCC-Cancer-Sub-Banner-Liver-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/liver-cancer/treatment-optionshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Liver-01.jpgBRCC-Cancer-Sub-Banner-Liver-01BRCC-Cancer-Sub-Banner-Liver-012026-04-30https://blueridgecancercare.com/locations/blacksburg2026-06-02https://blueridgecancercare.com/physicians/joshua-morales-md2026-07-29https://blueridgecancercare.com/liver-cancer/diagnosishttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Liver-01.jpgBRCC-Cancer-Sub-Banner-Liver-01BRCC-Cancer-Sub-Banner-Liver-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/non-hodgkin-lymphomahttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Non-Hodgkin-Lymphoma-01.jpgBRCC-Cancer-Sub-Banner-Non-Hodgkin-Lymphoma-01BRCC-Cancer-Sub-Banner-Non-Hodgkin-Lymphoma-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/research-institute/available-trials/epcoritamab-rituximab-and-lenalidomide-vs.-chemoimmunotherapy-in-previously-untreated-follicular-lymphoma2026-07-02https://blueridgecancercare.com/advanced-practice-providers/amy-bramblett-robinson-pa-c2026-04-29https://blueridgecancercare.com/emergencies-phone-callshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-06-24https://blueridgecancercare.com/nonmelanoma-skin-cancer/treatment-optionshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Non-Melanoma-Skin-01.jpgBRCC-Cancer-Sub-Banner-Non-Melanoma-Skin-01BRCC-Cancer-Sub-Banner-Non-Melanoma-Skin-012026-04-30https://blueridgecancercare.com/advanced-practice-providers/brigitta-brecht-pa-c2026-04-29https://blueridgecancercare.com/melanomahttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Melanoma-01.jpgBRCC-Cancer-Sub-Banner-Melanoma-01BRCC-Cancer-Sub-Banner-Melanoma-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/non-hodgkin-lymphoma/staginghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Non-Hodgkin-Lymphoma-01.jpgBRCC-Cancer-Sub-Banner-Non-Hodgkin-Lymphoma-01BRCC-Cancer-Sub-Banner-Non-Hodgkin-Lymphoma-012026-04-30https://blueridgecancercare.com/research-institute/available-trials/ono-4578-opdivo-mfolfox6-vs-soc-in-first-line-treatment-of-metastatic-colon-cancer2026-07-02https://blueridgecancercare.com/locations/wytheville2026-06-02https://blueridgecancercare.com/physicians/eric-pierce-md2026-07-13https://blueridgecancercare.com/cervical-cancerhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Cervical-01.jpgBRCC-Cancer-Sub-Banner-Cervical-01BRCC-Cancer-Sub-Banner-Cervical-012026-04-30https://blueridgecancercare.com/advanced-practice-providers/tamela-meador-msn-np-c2026-04-29https://blueridgecancercare.com/research-institute/available-trials/https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC%20Research%20Institute%202026.pngBRCC Research Institute 2026BRCC Research Institute 2026https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-07-02https://blueridgecancercare.com/bladder-cancer/diagnosishttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Bladder-01.jpgBRCC-Cancer-Sub-Banner-Bladder-01BRCC-Cancer-Sub-Banner-Bladder-012026-04-30https://blueridgecancercare.com/physicians/padmaja-v-mallidi-md2026-07-13https://blueridgecancercare.com/physicians/suzan-r-merten-md2026-07-13https://blueridgecancercare.com/colon-rectal-cancer/diagnosishttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Colon-01.jpgBRCC-Cancer-Sub-Banner-Colon-01BRCC-Cancer-Sub-Banner-Colon-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/colon-rectal-cancer/biomarker-testinghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Colon-01.jpgBRCC-Cancer-Sub-Banner-Colon-01BRCC-Cancer-Sub-Banner-Colon-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/radiation-therapyhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-07-09https://blueridgecancercare.com/research-institutehttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC%20Research%20Institute%202026.pngBRCC Research Institute 2026BRCC Research Institute 2026https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/research/understanding-clinical-trialshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC%20Research%20Institute%202026.pngBRCC Research Institute 2026BRCC Research Institute 2026https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/hodgkin-lymphoma/treatment-optionshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Hodgkin-Lymphoma-01.jpgBRCC-Cancer-Sub-Banner-Hodgkin-Lymphoma-01BRCC-Cancer-Sub-Banner-Hodgkin-Lymphoma-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/physicians/andrew-e-fintel-do2026-07-13https://blueridgecancercare.com/prescriptionshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/leukemia/stages-classificationshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Leukemia-01.jpgBRCC-Cancer-Sub-Banner-Leukemia-01BRCC-Cancer-Sub-Banner-Leukemia-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/multiple-myeloma/diagnosishttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Multiple-Myeloma-01.jpgBRCC-Cancer-Sub-Banner-Multiple-Myeloma-01BRCC-Cancer-Sub-Banner-Multiple-Myeloma-012026-04-30https://blueridgecancercare.com/advanced-practice-providers/melissa-weiss-msn-fnp-c2026-04-29https://blueridgecancercare.com/research-institute/available-trials/177lu-lu-dota-tate-in-patients-newly-diagnosed-with-grade-1-and-grade-2-advanced-gep-net2026-07-02https://blueridgecancercare.com/breast-cancer/staginghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Breast-01.jpgBRCC-Cancer-Sub-Banner-Breast-01BRCC-Cancer-Sub-Banner-Breast-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/research-institute/available-trials/study-of-bms-986489-vs-durvalumab-in-limited-stage-small-cell-lung-cancer2026-07-02https://blueridgecancercare.com/kidney-cancer/staginghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Site-Sub-00-Kidney-Cancer.jpgBRCC-Site-Sub-00-Kidney-CancerBRCC-Site-Sub-00-Kidney-Cancerhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/small-cell-lung-cancer/staginghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Small-Cell-01.jpgBRCC-Cancer-Sub-Banner-Small-Cell-01BRCC-Cancer-Sub-Banner-Small-Cell-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/prostate-cancer/treatment-optionshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Prostate-01.jpgBRCC-Cancer-Sub-Banner-Prostate-01BRCC-Cancer-Sub-Banner-Prostate-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-05-22https://blueridgecancercare.com/modules2026-04-09https://blueridgecancercare.com/locations/princeton2026-06-02https://blueridgecancercare.com/advanced-practice-providers/elizabeth-abel-pa-c2026-04-29https://blueridgecancercare.com/small-cell-lung-cancer/treatment-optionshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Small-Cell-01.jpgBRCC-Cancer-Sub-Banner-Small-Cell-01BRCC-Cancer-Sub-Banner-Small-Cell-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-06-11https://blueridgecancercare.com/endometrial-cancerhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Endometrial-01.jpgBRCC-Cancer-Sub-Banner-Endometrial-01BRCC-Cancer-Sub-Banner-Endometrial-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/research-institute/available-trials/zilovertamab-vedotin-soc-in-participants-with-dlbcl2026-07-02https://blueridgecancercare.com/research-institute/available-trials/rilvegostomig-chemo-for-1st-line-treatment-of-patients-with-metastatic-non-squamous-nsclc-with-pdl1-expression2026-07-02https://blueridgecancercare.com/types-of-cancer/https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-28https://blueridgecancercare.com/physicians/bret-adams-md-phd2026-07-13https://blueridgecancercare.com/small-cell-lung-cancer/diagnosishttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Small-Cell-01.jpgBRCC-Cancer-Sub-Banner-Small-Cell-01BRCC-Cancer-Sub-Banner-Small-Cell-012026-04-30https://blueridgecancercare.com/advanced-practice-providers/molly-edwards-msn-fnp-c2026-04-29https://blueridgecancercare.com/advanced-practice-providers/jessica-hill-fnp2026-04-29https://blueridgecancercare.com/appointmentshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/physicians/karanita-m-ojomo-md2026-07-13https://blueridgecancercare.com/advanced-practice-providers/laurie-nelson-lester-fnp2026-04-29https://blueridgecancercare.com/leukemiahttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Leukemia-01.jpgBRCC-Cancer-Sub-Banner-Leukemia-01BRCC-Cancer-Sub-Banner-Leukemia-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/research-institute/available-trials/a-double-blind-trial-of-pf-08634404-chemo-vs.-bevacizumab-chemo-in-untreated-colon-cancer2026-07-02https://blueridgecancercare.com/for-medical-professionalshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Alan-Repasky-Oncology-liason.jpgBRCC-Alan-Repasky-Oncology-liasonBRCC-Alan-Repasky-Oncology-liasonhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-29https://blueridgecancercare.com/advanced-practice-providers/matthew-manico-pa-c2026-04-30https://blueridgecancercare.com/oral-cancer/diagnosishttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Oral-01.jpgBRCC-Cancer-Sub-Banner-Oral-01BRCC-Cancer-Sub-Banner-Oral-012026-04-30https://blueridgecancercare.com/research-institute/available-trials/pf-08634404-monotherapy-or-in-combination-wenfortumab-vedotin-in-patients-with-urothelial-cancer2026-07-02https://blueridgecancercare.com/non-small-cell-lung-cancer/treatment-optionshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Non-Small-Cell-Lung-01.jpgBRCC-Cancer-Sub-Banner-Non-Small-Cell-Lung-01BRCC-Cancer-Sub-Banner-Non-Small-Cell-Lung-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-06-11https://blueridgecancercare.com/leukemia/treatment-optionshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Leukemia-01.jpgBRCC-Cancer-Sub-Banner-Leukemia-01BRCC-Cancer-Sub-Banner-Leukemia-012026-04-30https://blueridgecancercare.com/research-institute/available-trials/mcla-158-petosemtamab-as-single-agent-or-in-combination-in-advanced-solid-tumors2026-07-02https://blueridgecancercare.com/hodgkin-lymphomahttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Hodgkin-Lymphoma-01.jpgBRCC-Cancer-Sub-Banner-Hodgkin-Lymphoma-01BRCC-Cancer-Sub-Banner-Hodgkin-Lymphoma-012026-04-30https://blueridgecancercare.com/research-institute/available-trials/dato-dxd-wor-wo-durvalumab-vs-investigators-choice-in-patients-with-pdl1-triple-negative-breast-cancer2026-07-02https://blueridgecancercare.com/research-institute/available-trials/adjuvant-sacituzumab-govitecan-pembrolizumab-vs.-soc-tx-in-patients-with-tnbc2026-07-02https://blueridgecancercare.com/hematologyhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/sarcoma/diagnosishttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Sarcoma-01.jpgBRCC-Cancer-Sub-Banner-Sarcoma-01BRCC-Cancer-Sub-Banner-Sarcoma-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/research-institute/available-trials/mk-2870-monotherapy-or-in-combination-with-other-anticancer-agents-in-gastrointestinal-cancers2026-07-02https://blueridgecancercare.com/research-institute/available-trials/phase-3-study-of-mrtx849-cetuximab-vs.-chemo-in-patients-with-colon-cancer-wkras-g12c-mutation2026-07-02https://blueridgecancercare.com/breast-cancer/detection-diagnosishttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Breast-01.jpgBRCC-Cancer-Sub-Banner-Breast-01BRCC-Cancer-Sub-Banner-Breast-012026-04-30https://blueridgecancercare.com/research-institute/available-trials/luspatercept-vs.-epoetin-alfa-for-the-treatment-of-anemia-due-to-low-risk-mds2026-07-02https://blueridgecancercare.com/locations/bedford2026-06-02https://blueridgecancercare.com/research-institute/available-trials/zanidatamab-physicians-choice-chemo-vs.-trastzumab-physicians-choice-chemo-for-stage-iv-her2-breast-cancer2026-07-02https://blueridgecancercare.com/research-institute/available-trials/a-phase-ii-study-investigating-fruquintinib-plus-folfiri-as-second-line-treatment-for-participants-with-metastatic-colorectal-cancer2026-07-02https://blueridgecancercare.com/thyroid-cancer/staginghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Thyroid-01.jpgBRCC-Cancer-Sub-Banner-Thyroid-01BRCC-Cancer-Sub-Banner-Thyroid-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/advanced-practice-providers/lucia-kulhavy-pa-c2026-04-29https://blueridgecancercare.com/research-institute/available-trials/mevrometostatplacebo-enzalutamide-in-previously-treated-prostate-cancer-patients2026-07-02https://blueridgecancercare.com/advanced-practice-providers/mclendon-pruette-np-bc2026-04-30https://blueridgecancercare.com/research-institute/available-trials/etentamig-d-vs-daratumumab-lenalidomide-dexamethasone-in-patients-with-newly-diagnosed-mm2026-07-02https://blueridgecancercare.com/endometrial-cancer/diagnosishttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Endometrial-01.jpgBRCC-Cancer-Sub-Banner-Endometrial-01BRCC-Cancer-Sub-Banner-Endometrial-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/bladder-cancerhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Bladder-01.jpgBRCC-Cancer-Sub-Banner-Bladder-01BRCC-Cancer-Sub-Banner-Bladder-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/research-institute/available-trials/outpatient-administration-of-teclistamab-or-talquetamab-for-multiple-myeloma-optecoptal2026-07-02https://blueridgecancercare.com/pay-my-billhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/mesothelioma/detection-diagnosishttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Mesothelioma-01.jpgBRCC-Cancer-Sub-Banner-Mesothelioma-01BRCC-Cancer-Sub-Banner-Mesothelioma-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/locations/roanoke2026-06-02https://blueridgecancercare.com/ovarian-cancer/diagnosishttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Ovarian-01.jpgBRCC-Cancer-Sub-Banner-Ovarian-01BRCC-Cancer-Sub-Banner-Ovarian-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/melanoma/staginghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Melanoma-01.jpgBRCC-Cancer-Sub-Banner-Melanoma-01BRCC-Cancer-Sub-Banner-Melanoma-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/for-your-first-visithttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/advanced-practice-providers/alison-byrd-walker-fnp2026-04-29https://blueridgecancercare.com/advanced-practice-providers/angela-graham-msn-aprn-fnp-c2026-04-29https://blueridgecancercare.com/insurancehttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/pharmacyhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-06-22https://blueridgecancercare.com/physicians/jerome-goldschmidt-md2026-07-29https://blueridgecancercare.com/locations/rocky-mount2026-06-02https://blueridgecancercare.com/research-institute/available-trials/dostarlimab-after-chemoradiation-in-pts-wlocally-advanced-unresected-hn-carcinoma2026-07-02https://blueridgecancercare.com/research-institute/available-trials/chemo-incb161734-in-previously-untreated-kras-g12d-mutated-metastatic-pancreatic-adenocarcinom2026-07-02https://blueridgecancercare.com/breast-cancer/hormone-receptorshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Breast-01.jpgBRCC-Cancer-Sub-Banner-Breast-01BRCC-Cancer-Sub-Banner-Breast-012026-04-30https://blueridgecancercare.com/advanced-practice-providers/jennifer-foster-dnp2026-04-29https://blueridgecancercare.com/research-institute/available-trials/ph3-study-of-fixed-dose-fianlimab-cemiplimab-vs-relatlimab-unresectable-or-met-melanoma2026-07-02https://blueridgecancercare.com/bladder-cancer/treatment-optionshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Bladder-01.jpgBRCC-Cancer-Sub-Banner-Bladder-01BRCC-Cancer-Sub-Banner-Bladder-012026-04-30https://blueridgecancercare.com/laboratoryhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/COLA.jpegCOLACOLAhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/logo-CLIA.pnglogo-CLIAlogo-CLIAhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-07-10https://blueridgecancercare.com/physicians/heather-brooks-md2026-07-13https://blueridgecancercare.com/research-institute/available-trials/avutometinib-sotorasib-in-patients-with-kras-g12c-mutant-nsclc2026-07-02https://blueridgecancercare.com/physicians/david-buck-md2026-07-13https://blueridgecancercare.com/kidney-cancer/treatment-optionshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Site-Sub-00-Kidney-Cancer.jpgBRCC-Site-Sub-00-Kidney-CancerBRCC-Site-Sub-00-Kidney-Cancerhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/physicians/kimberly-aderhold-do2026-07-29https://blueridgecancercare.com/colon-rectal-cancer/treament-optionshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Colon-01.jpgBRCC-Cancer-Sub-Banner-Colon-01BRCC-Cancer-Sub-Banner-Colon-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-06-11https://blueridgecancercare.com/physicians/john-rogers-md2026-07-13https://blueridgecancercare.com/research-institute/available-trials/phase-2-study-of-futibatinib-20-mg-and-16-mg-in-patients-with-advanced-cholangiocarcinoma-with-fgfr2-fusions-or-rearrangements2026-07-02https://blueridgecancercare.com/radiation-oncologyhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-24https://blueridgecancercare.com/physicians/giovanni-elia-md2026-07-13https://blueridgecancercare.com/endometrial-cancer/staginghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Endometrial-01.jpgBRCC-Cancer-Sub-Banner-Endometrial-01BRCC-Cancer-Sub-Banner-Endometrial-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/advanced-practice-providershttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/apps/BRCC_Dunbar.jpgBRCC_DunbarBRCC_Dunbarhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/apps/Jennifer_Foster_1-web.jpgJennifer_Foster_1-webJennifer_Foster_1-webhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/apps/Allison_Byrd_1-web.jpgAllison_Byrd_1-webAllison_Byrd_1-webhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/apps/Amy_Butler-r.jpgAmy_Butler-rAmy_Butler-rhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/apps/Amy_Bramblett-Robinson-r.jpgAmy_Bramblett-Robinson-rAmy_Bramblett-Robinson-rhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/apps/Weiss_2.jpgWeiss_2Weiss_2https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/apps/BRCC_Hillard_hallway-no_jacket.jpgBRCC_Hillard_hallway-no_jacketBRCC_Hillard_hallway-no_jackethttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/apps/Abel.jpgAbelAbelhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/apps/Lucia_Kulhavy-r.jpgLucia_Kulhavy-rLucia_Kulhavy-rhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/apps/Charlene_Jordan-r.jpgCharlene_Jordan-rCharlene_Jordan-rhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/apps/Char_Viers_web.jpgChar_Viers_webChar_Viers_webhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/apps/Edwards_2.jpgEdwards_2Edwards_2https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/apps/Megan_Mellow_web.jpgMegan_Mellow_webMegan_Mellow_webhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/apps/Hill.jpgHillHillhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/apps/Brigitta_Brech-r.jpgBrigitta_Brech-rBrigitta_Brech-rhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/apps/Lester.jpgLesterLesterhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/apps/Preston.jpgPrestonPrestonhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/apps/Matthew_Manico-r.jpgMatthew_Manico-rMatthew_Manico-rhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/apps/A_Graham_2.jpgA_Graham_2A_Graham_2https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/apps/Kristin_Auckland_web.jpgKristin_Auckland_webKristin_Auckland_webhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/apps/Christman.jpgChristmanChristmanhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/apps/E._McClendon_Pruett_3-web.jpgE._McClendon_Pruett_3-webE._McClendon_Pruett_3-webhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/apps/Meador.jpgMeadorMeador2026-04-29https://blueridgecancercare.com/research-institute/available-trials/sac-tmt-carbopaclitaxel-vs-chemo-both-with-pembro-as-neoadjuvant-treatment-for-tnb2026-07-02https://blueridgecancercare.com/research-institute/available-trials/mezigdomide-carfilzomib-and-dex-vs.-carfilzomib-and-dex-in-participants-with-mm2026-07-02https://blueridgecancercare.com/thyroid-cancer/treatment-optionshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Thyroid-01.jpgBRCC-Cancer-Sub-Banner-Thyroid-01BRCC-Cancer-Sub-Banner-Thyroid-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/thyroid-cancerhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Thyroid-01.jpgBRCC-Cancer-Sub-Banner-Thyroid-01BRCC-Cancer-Sub-Banner-Thyroid-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-04-30https://blueridgecancercare.com/advanced-practice-providers/danny-dunbar-pa-c2026-04-29https://blueridgecancercare.com/research-institute/available-trials/bgb-16673-vs.-pirtobrutinib-in-patients-wrelapsedrefractory-cll-or-sll2026-07-02https://blueridgecancercare.com/non-small-cell-lung-cancer/staginghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Non-Small-Cell-Lung-01.jpgBRCC-Cancer-Sub-Banner-Non-Small-Cell-Lung-01BRCC-Cancer-Sub-Banner-Non-Small-Cell-Lung-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/abouthttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC%20About%20Us.jpgBRCC About UsBRCC About Ushttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraph2026-06-22https://blueridgecancercare.com/prostate-cancer/staginghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Prostate-01.jpgBRCC-Cancer-Sub-Banner-Prostate-01BRCC-Cancer-Sub-Banner-Prostate-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/breast-cancerhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Breast-01.jpgBRCC-Cancer-Sub-Banner-Breast-01BRCC-Cancer-Sub-Banner-Breast-012026-04-30https://blueridgecancercare.com/oral-cancer/staginghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Oral-01.jpgBRCC-Cancer-Sub-Banner-Oral-01BRCC-Cancer-Sub-Banner-Oral-012026-04-30https://blueridgecancercare.com/research-institute/available-trials/petosemtamab-pembrolizumab-vs.-pembrolizumab-in-1st-line-treatment-of-pd-l1-head-neck-squamous-cell-carcinoma2026-07-02https://blueridgecancercare.com/practice-newshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30https://blueridgecancercare.com/quality-programshttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logohttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/ASCO-Certified-Emblem-RGB-TM%5B84%5D%20(1).pngASCO-Certified-Emblem-RGB-TM[84] (1)ASCO-Certified-Emblem-RGB-TM[84] (1)2026-06-22https://blueridgecancercare.com/locations/fairlea2026-06-02https://blueridgecancercare.com/liver-cancer/staginghttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-OpenGraph.jpgBRCC-OpenGraphBRCC-OpenGraphhttps://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC-Cancer-Sub-Banner-Liver-01.jpgBRCC-Cancer-Sub-Banner-Liver-01BRCC-Cancer-Sub-Banner-Liver-01https://51279512.fs1.hubspotusercontent-na1.net/hubfs/51279512/BRCC_Logo.svgBRCC_LogoBRCC_Logo2026-04-30